Across TCGA pan-cancer cohorts, BPIFA4P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated BPIFA4P data layer compared with 19 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher BPIFA4P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated BPIFA4P expression acts as an unfavorable survival marker.

UCEC are the cancer types where BPIFA4P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: BPIFA4P tumor-vs-normal RNA expression · all BPIFA4P data types